Regulatory Actions

STAAR Surgical Reports Second Quarter Results

Published in Medical Letter on the CDC and FDA, August 26th, 2007

STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced financial results for its second quarter ended June 29, 2007.

Total product sales for the second quarter were $14,932,000, an increase of 1.4% compared with $14,733,000 reported for the same period of 2006. The year-over-year increase in sales during the second quarter of 2007 was largely the result of increased international sales within all product categories. The impact of changes in currency on second quarter 2007 sales was approximately $440,000.

For the first six months of 2007, total product sales were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-08-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry